Ian Ardill, BSc ACA – Chief Financial Officer, Diurnal
Ian Ardill is Chief Financial Officer of Diurnal and joined the Group in April 2015. Ian has over 20 years’ experience in senior financial positions. Before joining the Group, Ian was CFO of two listed companies: Lombard Medical Technologies plc for over three years and Biocompatibles International plc for over six years. At Lombard Medical, Ian led the company financially through the late stages of FDA pre-market approval and the commencement of US commercial operations. On the financing front, he managed a £22 million AIM fundraising and the company’s $55 million NASDAQ IPO, involving the cancellation of admission to trading on AIM and a re-domicile.
At Biocompatibles,Ian played a leading role in transforming the company from a loss-making to a profitable enterprise with sales of £33 million. He also managed the successful £177 million sale of the business to BTG Plc in 2011 and two returns of capital to shareholders totalling £23 million. In addition, Ian was responsible for the implementation of a dividend programme at Biocompatibles. Ian has also worked at Novartis Pharmaceuticals, the Compass Group, NHA International and Grant Thornton. Ian is a qualified chartered accountant.